OTTAWA (dpa-AFX) - Bausch Health Companies Inc. (BHC, BHC.TO) reported that its net income attributable to the company for the third quarter of 2025 was $179 million or $0.48 per share, compared to net loss of $85 million or $0.23 per share for the third quarter of 2024, an increase of $264 million.
BHC closed Wednesday's regular trading at $5.90 down $0.29 or 4.68%. But in the after-hours trading the stock gained $0.43 or 7.29%.
Consolidated adjusted net income attributable to the company for the third quarter of 2025 was $434 million, compared with $415 million for the third quarter of 2024, an increase of $19 million, primarily due to an increase in contribution and lower selling, general, and administrative expense, partially offset by higher interest expense.
Total consolidated reported revenues were $2.68 billion for the third quarter of 2025, compared with $2.51 billion in the third quarter of 2024, an increase of $171 million, or 7%. Excluding the impact of foreign exchange of $29 million, acquisitions of $3 million, and divestitures and discontinuations which negatively impacted the prior year by $3 million, revenue increased 5% on an organic1 basis compared with the third quarter of 2024.
Analysts expected the company to report earnings of $1.06 per share and revenues of $2.63 billion for the third quarter. Analysts' estimates typically exclude special items.
The company raised full-year 2025 revenue, Adjusted EBITDA, and Adjusted Cash Flow from Operations guidance.
The company now expects annual revenues to be in the range of $10.050 billion - $10.250 billion. Analysts expect revenue of $10.12 billion for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
